Typical CT manifestations | Immunocompromised patients | Immunocompetent patients | ||||||
---|---|---|---|---|---|---|---|---|
tN | Rate (%) | 95% CI | I2 (%) | tN | Rate (%) | 95% CI | I2 (%) | |
Air bronchogram sign | 126 | 33.5 | 8.5–58.4 | 92.2 | 161 | 36.9 | 17.3–56.4 | 88.9 |
Halo sign | 126 | 38.3 | 24.7–52.0 | 60.4 | 161 | 31.4 | 12.1–50.7 | 91.1 |
Cavitation | 220 | 39.8 | 31.3–48.2 | 31.3 | 203 | 10.5 | 6.3–14.7 | 0.0 |
Pleural effusion | 220 | 13.0 | 8.1–17.9 | 9.6 | 203 | 5.3 | 0.8–9.8 | 34.2 |
Ground-glass attenuation | 161 | 23.2 | 13.9–32.5 | 41.8 | 89 | 4.7 | 0.0–11.8 | 40.8 |
Consolidations | 212 | 21.3 | 15.7–27.0 | 0.0 | 173 | 19.2 | 13.4–25.0 | 0.0 |
Enlarged mediastinal lymph nodes | 211 | 12.3 | 7.9–16.7 | 0.0 | 190 | 7.2 | 2.4–11.9 | 17.1 |
Solitary nodule | 222 | 26.8 | 11.7–41.9 | 88.1 | 202 | 34.0 | 13.6–54.4 | 91.8 |
Multiple nodules | 222 | 53.6 | 38.6–68.7 | 79.9 | 202 | 52.3 | 35.3–69.2 | 85.5 |
Mass | 128 | 18.2 | 9.1–27.3 | 43.3 | 160 | 22.8 | 15.7–29.9 | 0.0 |